The FASEB Journal, Vol 7, 580-585, Copyright © 1993 by The Federation of American Societies for Experimental Biology

RESEARCH COMMUNICATIONS

Cyclic AMP potentiates glucocorticoid-induced endogenous endonuclease activation in thymocytes

DJ McConkey, S Orrenius, S Okret and M Jondal
Department of Toxicology, Karolinska Institutet, Stockholm, Sweden.

The present study was undertaken to determine whether specific interactions between cAMP and glucocorticoids regulate apoptosis in thymocytes. Incubation of murine thymocytes with agents that elevate the cAMP level resulted in enhancement of glucocorticoid-induced Ca2+ increases, DNA fragmentation, and cell death compared to levels observed in thymocytes treated with steroid alone. cAMP did not affect DNA fragmentation in thymocytes treated with Ca2+ ionophore, a compound that induces endonuclease activation via an independent mechanism. Treatment with cAMP also increased glucocorticoid potency by lowering the concentration of steroid required for induction of apoptosis. The mechanism of cAMP action appeared to involve the glucocorticoid receptor, since the glucocorticoid antagonist RU-486 abrogated the cAMP response in animals treated with the adenosine analog NECA in vivo. Analysis of cellular glucocorticoid binding and receptor protein levels revealed modest cAMP-stimulated increases that appeared insufficient to account for the effects of cAMP on endogenous endonuclease activation, suggesting the possible involvement of a posttranslational mechanism in the response. These results demonstrate that cAMP and glucocorticoids synergize to promote apoptosis in thymocytes via a mechanism that appears to involve modification of glucocorticoid receptor activity.

This article has been cited by other articles:

				L. Zhang and P. A. Insel The Pro-apoptotic Protein Bim Is a Convergence Point for cAMP/Protein Kinase A- and Glucocorticoid-promoted Apoptosis of Lymphoid Cells J. Biol. Chem., May 14, 2004; 279(20): 20858 - 20865. [Abstract] [Full Text] [PDF]

				R. Ogawa, M. B. Streiff, A. Bugayenko, and G. J. Kato Inhibition of PDE4 phosphodiesterase activity induces growth suppression, apoptosis, glucocorticoid sensitivity, p53, and p21WAF1/CIP1 proteins in human acute lymphoblastic leukemia cells Blood, May 1, 2002; 99(9): 3390 - 3397. [Abstract] [Full Text] [PDF]

				W. Savino and M. Dardenne Neuroendocrine Control of Thymus Physiology Endocr. Rev., August 1, 2000; 21(4): 412 - 443. [Abstract] [Full Text] [PDF]

				R. H. STRAUB, H.-J. LINDE, D. N. MÄNNEL, J. SCHÖLMERICH, and W. FALK A bacteria-induced switch of sympathetic effector mechanisms augments local inhibition of TNF-{alpha} and IL-6 secretion in the spleen FASEB J, July 1, 2000; 14(10): 1380 - 1388. [Abstract] [Full Text]

				L Garcia-Bermejo, C Perez, N. Vilaboa, E de Blas, and P Aller cAMP increasing agents attenuate the generation of apoptosis by etoposide in promonocytic leukemia cells J. Cell Sci., January 3, 1998; 111(5): 637 - 644. [Abstract] [PDF]

				D. McConkey and S Orrenius Signal transduction pathways in apoptosis Stem Cells, November 1, 1996; 14(6): 619 - 631. [Abstract]